Keywords: Atherosclerosis, Heart
Motivation: Compared with primary percutaneous coronary intervention (PPCI), it is not known whether patients with ST-elevation myocardial infarction (STEMI) benefit from thrombolysis prior to PCI within 120 minutes of symptom onset.
Goal(s): This study was to compare the short-term performance between STEMI patients with and without a single bolus recombinant staphylokinase (r-SAK) prior to PCI by Cardiac Magnetic Resonance (CMR) imaging.
Approach: The global and segmental [mainly focusing on LGE+ segment (transmural extent >50%)] CMR parameters were compared between r-SAK group and control group.
Results: Patients can benefit from thrombolysis prior to PCI with better myocardial function and smaller extent of edema.
Impact: This study investigated the short-term advantages of adjunctive thrombolysis with r-SAK for STEMI patients undergoing PCI. A single bolus r-SAK intravenously prior to PCI for STEMI improves myocardial function and reduces the extent of edema.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords